Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2004-000646-20-IT
EUCTR2004-000646-20-IT
Active, not recruiting
Not Applicable

TRIUMPH A Hemoglobin Stabilization and Transfusion Reduction Efficacy and Safety Clinical Investigation, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Using Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Patients

ALEXION PHARMACEUTICALS INC0 sites75 target enrollmentDecember 23, 2005
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionspaaroxysmal nocturnal hemoglobinuriaMedDRA version: 6.1Level: PTClassification code 10034042

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
paaroxysmal nocturnal hemoglobinuria
Sponsor
ALEXION PHARMACEUTICALS INC
Enrollment
75
Status
Active, not recruiting
Last Updated
14 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 23, 2005
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
A Hemoglobin Stabilization and Transfusion Reduction Efficacy and Safety Clinical Investigation, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Using Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Patients - TRIUMPHparoxysmal nocturnal hemoglobinuriaMedDRA version: 7.0Level: PTClassification code 10034042
EUCTR2004-000646-20-SEALEXION PHARMACEUTICALS INCORPORATED75
Active, not recruiting
Phase 1
A Hemoglobin Stabilization and Transfusion Reduction Efficacy and Safety Clinical Investigation, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Using Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Patients - TRIUMPH
EUCTR2004-000646-20-IEALEXION PHARMACEUTICALS INCORPORATED75
Active, not recruiting
Phase 1
A Hemoglobin Stabilization and Transfusion Reduction Efficacy and Safety Clinical Investigation, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Using Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Patients - TRIUMPH
EUCTR2004-000646-20-GBALEXION PHARMACEUTICALS INCORPORATED109
Recruiting
Not Applicable
Examination of the perioperative period hemoglobin and a renal function by patient of hepatocellular carcinoma who undergoes intraoperative blood salvage for a extraction operation.hepatocellular carcinoma
JPRN-UMIN000012422Kansai Medical University50
Completed
Not Applicable
Intraoperative, continous non invasive haemoglobin measurement in infants and childreD64Other anaemias
DRKS00004188Medizinische Universität Wien39